EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC-ND 4.0

Determinants of Branded versus Generic Positioning Strategies in the Pakistani Pharmaceutical Market: A Cross-Sectional Survey of Industry Practice

Hafiz Usman Ghani

International Journal of Business and Management Sciences · 31.07.2026 · 7 (5) · 245-251

DOI: 10.63468/ijbms.7.5.17 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Business and Management Sciences, online erschienen am 31.07.2026. Verfasst von Hafiz Usman Ghani. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global pharmaceutical industry is undergoing a structural shift as patents on major branded products expire, driving increased reliance on generic manufacturing. In emerging and “pharmerging” markets such as Pakistan, this shift interacts with local regulatory frameworks, pricing controls, and market-access strategies in ways that remain poorly documented at the firm level. To explore how patent status, therapeutic area focus, pricing strategy, regulatory environment, population aging, competitive intelligence practices, and launch strategy affect the positioning of branded versus generic pharmaceutical products among companies operating in Pakistan. This was an exploratory, cross-sectional study using both secondary data (industry reports, regulatory documents, and published literature) and primary data collected via a structured, self-reported questionnaire administered to medical representatives of pharmaceutical companies (target n=195), selected using [sampling method — see Note on Methodology below]. Data were summarized using descriptive percentage analysis and presented in tabular and graphical form. Of respondents, 69.7% reported promoting generic products versus 30.3% promoting branded products; among branded products, 91.5% had expired patents. Companies reported that 82.1% of pipeline products were generic versus 17.9% branded. Respiratory disease was the most frequently targeted therapeutic area (60.5%), followed by analgesics/narcotic analgesics (50.7%) and antidiabetics (37.8%). A low-priced brand strategy was used by 73.85% of companies to access the Pakistani market, versus 4.61% using a high-priced strategy and 21.53% using a mixed approach. Distribution/dealer networks were reported by 96.91% of companies, and business-to-business (B2B) selling was considered the most profitable marketing approach by 85.6%. Nearly all companies (96.9%) reported engaging in competitive intelligence gathering. Regarding launch strategy, 85.6% of companies used a single-launch approach, with 81.0% prioritizing rapid market establishment within the first six months; 51.8% reported achieving 80–90% of their launch objectives. Pharmaceutical companies operating in Pakistan predominantly favor generic products and low-priced brand strategies, consistent with global trends toward genericization following patent expiry. Respiratory, analgesic, and antidiabetic therapeutic areas dominate industry focus. The absence of formal regulation governing pharmaceutical marketing conduct toward physicians represents a persistent regulatory gap. These findings are descriptive in nature; the study did not employ inferential statistical testing, and results should be interpreted as hypothesis-generating rather than confirmatory.

Zitieren

APA

Ghani, H. U. (2026). Determinants of Branded versus Generic Positioning Strategies in the Pakistani Pharmaceutical Market: A Cross-Sectional Survey of Industry Practice. International Journal of Business and Management Sciences, 7(5), 245-251. https://doi.org/10.63468/ijbms.7.5.17

Vancouver

Ghani HU. Determinants of Branded versus Generic Positioning Strategies in the Pakistani Pharmaceutical Market: A Cross-Sectional Survey of Industry Practice. International Journal of Business and Management Sciences. 2026;7(5):245-251. doi:10.63468/ijbms.7.5.17

BibTeX
@article{Ghani2026,
  author = {Ghani, Hafiz Usman},
  title = {Determinants of Branded versus Generic Positioning Strategies in the Pakistani Pharmaceutical Market: A Cross-Sectional Survey of Industry Practice},
  journal = {International Journal of Business and Management Sciences},
  year = {2026},
  volume = {7},
  number = {5},
  pages = {245--251},
  doi = {10.63468/ijbms.7.5.17}
}
Kostenlos starten →